Investor conferences - seeking investors for clincal phase IIb funding
|Coordinator||Stayble Therapeutics AB|
|Funding from Vinnova||SEK 15 000|
|Project duration||February 2019 - February 2019|
Purpose and goal
The goal with the project is to by attending two investor meeting identify potential new investors that would be interested in investing in Stayble´s up-coming investment round.
Expected results and effects
The expected result is to connect with new investors relevant for the next investment round.
Planned approach and implementation
Participation at tw o investor congresses: - LSX W orld Congress (London, 5-6/2 2019) - Sw iss Nordic Bio (Zürich, 7/2 2019)